Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Medicare Shakeup: Policy Changes Rattle Big Insurers

by Team Lumida
May 17, 2024
in Macro, News
Reading Time: 4 mins read
A A
0
emergency signage

Photo by Pixabay on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Biden administration’s policy changes reduce Medicare Advantage profitability.
  2. Insurers like CVS and Humana face rising costs and declining profits.
  3. Market and regulatory challenges could reshape the future of Medicare Advantage.

What Happened?

The Medicare Advantage landscape has dramatically shifted. Medicare Advantage, a program where the government pays insurers to manage senior care, has been a major profit driver for companies like UnitedHealth Group and Humana. However, the Biden administration’s recent policy changes have altered the payment structures, causing a significant dip in profitability.

CVS Health’s Aetna unit reported a $900 million surge in unexpected medical costs, leading to its largest one-day share drop in nearly 15 years. As a result, CVS shares have plunged 26% this year, equating to a market cap of just over $70 billion—the same amount it paid for Aetna in 2018. Humana and UnitedHealth have also seen their shares drop by over 20% and 16%, respectively.

Why It Matters?

These changes have rattled investors and corporate boards, signaling a shift from growth to profitability in the Medicare Advantage sector. With the government tightening its purse strings and implementing stricter policies, insurers must adapt quickly. CVS plans to exit some markets and cut back on benefits to improve margins.

Thomas Cowhey, CVS Chief Financial Officer, stated, “The goal for next year is margin over membership.” This shift could open opportunities for companies with better profit margins like UnitedHealth to gain market share. However, the regulatory environment remains a tougher challenge, with tighter payment rates and changes in coding patient risk.

What’s Next?

Insurers are now focusing on mitigating rising costs and adapting to new regulations. Expect strategic exits from less profitable markets and reductions in member benefits. Analysts predict Humana, despite expected lower earnings this year, will rebound to $26 per share by 2026. The industry’s lobbying efforts will intensify to influence public and policymaker opinions.

Wendell Potter, a former Cigna executive, highlighted, “Companies will be investing heavily through campaign donations and lobbying.” A potential Donald Trump win in the upcoming presidential elections could favor privatization and benefit Medicare Advantage. Regardless, the sector remains profitable but without the extraordinary gains seen in recent years.

Source: WSJ
Previous Post

Why Bitcoin’s Correlation with Nasdaq Is Skyrocketing

Next Post

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Recommended For You

Tesla Faces Sales Slump Amid Competition, Political Backlash, and Delayed Innovation

by Team Lumida
19 hours ago
blue coupe parked beside white wall

Key Takeaways: Powered by lumidawealth.com Declining Sales: Tesla’s vehicle deliveries are on track to decline for the second consecutive year, with Q2 sales down 13% year-over-year and U.S. market...

Read more

Trump Signs $3.4 Trillion ‘Big, Beautiful Bill’ Into Law on Independence Day

by Team Lumida
19 hours ago
Tech Titans Pivot: Silicon Valley’s New Alliance in Trump’s Second Term

Key Takeaways: Powered by lumidawealth.com Major Legislative Win: President Trump signed a sweeping $3.4 trillion bill* into law, extending tax cuts, boosting military and immigration spending, and reducing social...

Read more

Xi Jinping’s Cold War Strategy: Lessons from the Soviet Union to Counter U.S. Rivalry

by Team Lumida
19 hours ago
Xi Jinping’s Cold War Strategy: Lessons from the Soviet Union to Counter U.S. Rivalry

Key Takeaways: Powered by lumidawealth.com Strategic Stalemate: Xi Jinping aims to achieve a “strategic stalemate” with the U.S., avoiding direct confrontation while preparing China for a prolonged competition. Learning...

Read more

Ether Holds Steady Above $2,580 as Strong U.S. Jobs Data Lifts Equities to Record Highs

by Team Lumida
2 days ago
gold and black star print round ornament

Key Takeaways: Powered by lumidawealth.com ETH Resilience: Ether (ETH) rose 0.55% over 24 hours, trading at $2,584.90* on July 3, supported by a broader risk-on sentiment in financial markets....

Read more

Goldman Sachs Lowers Treasury Yield Forecasts Amid Rising Fed Rate Cut Expectations

by Team Lumida
2 days ago
Goldman Sachs Urges Investors to Cut Risk: Is a Selloff Looming?

Key Takeaways: Powered by lumidawealth.com Revised Yield Forecasts: Goldman Sachs now expects 2-year Treasury yields to end 2025 at 3.45% and 10-year yields at 4.20%, down from previous forecasts...

Read more

China’s Share of US Imports Drops to 7% as Vietnam and Taiwan Gain Ground

by Team Lumida
2 days ago
Chinese Stock Surge: A Hedge Fund Headache?

Key Takeaways: Powered by lumidawealth.com China’s Declining Share: China’s share of US imports fell to 7.1% in May 2025, the lowest since 2001, down from 14.8% in September 2024....

Read more

Trump Secures Sweeping Economic Policy Shift as House Passes $3.4 Trillion Tax Bill

by Team Lumida
2 days ago
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Key Takeaways: Powered by lumidawealth.com Massive Tax Cuts: The bill includes $4.5 trillion in tax cuts*, extending Trump’s 2017 tax reforms and introducing new breaks for child tax credits,...

Read more

Del Monte Foods Files for Bankruptcy Amid Post-Pandemic Demand Decline and Debt Burden

by Team Lumida
3 days ago
Del Monte Foods Files for Bankruptcy Amid Post-Pandemic Demand Decline and Debt Burden

Key Takeaways: Powered by lumidawealth.com Bankruptcy Filing: Del Monte Foods, the U.S. unit of Del Monte Pacific, filed for Chapter 11 bankruptcy due to declining demand for canned goods...

Read more

Del Monte Foods Files for Bankruptcy Amid Post-Pandemic Demand Decline and Debt Burden

by Team Lumida
3 days ago
Del Monte Foods Files for Bankruptcy Amid Post-Pandemic Demand Decline and Debt Burden

Key Takeaways: Powered by lumidawealth.com Bankruptcy Filing: Del Monte Foods, the U.S. unit of Del Monte Pacific, filed for Chapter 11 bankruptcy due to declining demand for canned goods...

Read more

OpenAI Warns Against Unauthorized Tokenized Equity Sales on Robinhood

by Team Lumida
3 days ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways: Powered by lumidawealth.com Unauthorized Sales: OpenAI has stated that tokenized equity offerings on Robinhood’s platform are unauthorized and not endorsed by the company. Robinhood’s Tokenized Trading: Robinhood...

Read more
Next Post
woman with face mask holding an alcohol bottle

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

silver iphone 6 on black surface

Apple Taps Alibaba’s AI to Power iPhones, Boosting China Presence

February 13, 2025

Bunds on the Brink: Are Yields Set for a Reversal?

October 8, 2024
person holding black and white microscope

The Future of Longevity: AI and Nanorobots to Radically Extend Life

June 25, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018